These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19764837)

  • 1. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4.
    Donsmark M; Herold L; Kristensen CM
    Diabetes Technol Ther; 2009 Sep; 11(9):581-5. PubMed ID: 19764837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient acceptance and issues of education of two durable insulin pen devices.
    Asakura T; Seino H; Jensen KH
    Diabetes Technol Ther; 2008 Aug; 10(4):299-304. PubMed ID: 18715204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trigger matters: an ergonomy analysis of insulin pens.
    Fendler W; Roman-Liu D; Tokarski T; Romanczuk R; Mlynarski W
    Diabetes Technol Ther; 2015 Mar; 17(3):171-6. PubMed ID: 25607378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose accuracy and durability of the NovoPen 4 insulin delivery device before and after simulation of 5 years of use and under various stress conditions.
    Kristensen CM; Donsmark M
    Clin Ther; 2009 Dec; 31(12):2819-23. PubMed ID: 20110021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation.
    Joubert M; Haddouche A; Morera J; Rod A; Reznik Y
    Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinically relevant technical attributes of five insulin injection pens.
    Asakura T
    J Diabetes Sci Technol; 2011 Sep; 5(5):1203-9. PubMed ID: 22027319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection force of reusable insulin pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR.
    Friedrichs A; Korger V; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1185-90. PubMed ID: 22027315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions.
    Gudiksen N; Hofstätter T; Rønn BB; Sparre T
    Diabetes Technol Ther; 2017 Oct; 19(10):603-607. PubMed ID: 28704062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of 25 years' experience with the NovoPen family of insulin pens in the management of diabetes mellitus.
    Hyllested-Winge J; Jensen KH; Rex J
    Clin Drug Investig; 2010; 30(10):643-74. PubMed ID: 20701399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Force requirements and insulin delivery profiles of four injection devices.
    Toraishi K; Yuizono Y; Nakamura N; Kato S; Aoki T; Ashida K; Sako Y
    Diabetes Technol Ther; 2005 Aug; 7(4):629-35. PubMed ID: 16120038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens.
    Hemmingsen H; Niemeyer M; Hansen MR; Bucher D; Thomsen NB
    Diabetes Technol Ther; 2011 Dec; 13(12):1207-11. PubMed ID: 21864019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.
    Sommavilla B; Pietranera G
    J Diabetes Sci Technol; 2011 Sep; 5(5):1212-21. PubMed ID: 22027321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting.
    Friedrichs A
    Diabetes Technol Ther; 2009 Sep; 11(9):609-13. PubMed ID: 19764841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals.
    Olsen BS; Lilleøre SK; Korsholm CN; Kracht T
    J Diabetes Sci Technol; 2010 Nov; 4(6):1468-75. PubMed ID: 21129343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.
    Kadiri A; Chraibi A; Marouan F; Ababou MR; el Guermai N; Wadjinny A; Kerfati A; Douiri M; Bensouda JD; Belkhadir J; Arvanitis Y
    Diabetes Res Clin Pract; 1998 Jul; 41(1):15-23. PubMed ID: 9768368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of dose selection attributes with audible notification in insulin pen devices.
    Asakura T; Seino H
    Diabetes Technol Ther; 2005 Aug; 7(4):620-6. PubMed ID: 16120036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles.
    Iwanaga M; Kamoi K
    Diabetes Technol Ther; 2009 Feb; 11(2):81-6. PubMed ID: 19848573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose accuracy of new versus used Novopen 4 insulin pens.
    Yucel H; Taks M; Menheere P; Grouls R; Bravenboer B
    Diabetes Technol Ther; 2012 Sep; 14(9):810-2. PubMed ID: 22866889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient acceptability of a new 3.0 ml pre-filled insulin pen.
    D'Eliseo P; Blaauw J; Milicević Z; Wyatt J; Ignaut DA; Malone JK
    Curr Med Res Opin; 2000; 16(2):125-33. PubMed ID: 10893656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.